Helius Medical Valuation
| HSDT Stock | USD 0.49 0.03 6.52% |
Helius Medical is undervalued. Helius Medical Techn retains a regular Real Value of $32.42 per share. The prevalent price of the firm is $0.49. Our model calculates the value of Helius Medical Techn from evaluating the firm fundamentals such as Return On Asset of -0.76, return on equity of -1.62, and Shares Outstanding of 3.73 M as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Helius Medical's valuation include:
Price Book 0.4516 | Enterprise Value -1.7 M | Enterprise Value Ebitda (0.01) | Price Sales 2.8884 | Enterprise Value Revenue 0.1433 |
Undervalued
Today
Please note that Helius Medical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Helius Medical Techn is based on 3 months time horizon. Increasing Helius Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Helius Medical's intrinsic value may or may not be the same as its current market price of 0.49, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.49 | Real 32.42 | Target 128.33 | Hype 0.45 |
The intrinsic value of Helius Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Helius Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Helius Medical Technologies helps investors to forecast how Helius stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Helius Medical more accurately as focusing exclusively on Helius Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Helius Medical's intrinsic value based on its ongoing forecasts of Helius Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Helius Medical's closest peers.
Helius Medical Cash |
|
Helius Valuation Trend
Helius Medical's real value is important for investors to make better decisions and a more accurate overall view of Helius Medical's financial worth over time. Using both Helius Medical's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Helius Medical Total Value Analysis
Helius Medical Technologies is currently forecasted to have valuation of (1.73 M) with market capitalization of 1.72 M, debt of 57 K, and cash on hands of 3.27 M. The negative valuation of Helius Medical may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Helius Medical fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(1.73 M) | 1.72 M | 57 K | 3.27 M |
Helius Medical Investor Information
The company has price-to-book (P/B) ratio of 0.45. Some equities with similar Price to Book (P/B) outperform the market in the long run. Helius Medical Techn recorded a loss per share of 4.27. The entity last dividend was issued on the 4th of January 2021. The firm had 1:50 split on the 17th of August 2023. Based on the analysis of Helius Medical's profitability, liquidity, and operating efficiency, Helius Medical Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Helius Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Helius Medical has an asset utilization ratio of 8.37 percent. This implies that the Company is making $0.0837 for each dollar of assets. An increasing asset utilization means that Helius Medical Technologies is more efficient with each dollar of assets it utilizes for everyday operations.Helius Medical Ownership Allocation
Roughly 93.68 (percent) of Helius Medical outstanding shares are held by general public with 0.52 % owned by insiders and only 5.8 pct. by outside corporations.Helius Medical Profitability Analysis
The company reported the previous year's revenue of 644 K. Net Loss for the year was (8.85 M) with profit before overhead, payroll, taxes, and interest of 324 K.About Helius Medical Valuation
The stock valuation mechanism determines Helius Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Helius Medical Techn based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Helius Medical. We calculate exposure to Helius Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Helius Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 61 K | 58 K | |
| Pretax Profit Margin | (13.74) | (14.43) | |
| Operating Profit Margin | (19.30) | (20.26) | |
| Net Loss | (13.74) | (14.43) | |
| Gross Profit Margin | 0.09 | 0.09 |
Helius Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Helius Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 607.9 K |
Helius Medical Current Valuation Indicators
Helius Medical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Helius Medical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Helius Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Helius Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Helius Medical's worth.Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.